Optineurin Antibody (Rabbit mAb) [D24C11]

Catalog No.: F9272

    Application: Reactivity:
    • Lane 1: MCF7, Lane 2: U-2OS, Lane 3: Mouse retina, Lane 4: Rat retina
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:500 - 1:1000
    1:40
    1:500
    Application
    WB, IP, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    66 kDa 73 kDa, 68 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human skeletal muscle; Mouse retina; Rat retina; Rat brain; Rat heart; Mouse placenta; Human cerebrum; Rat cerebellum; Human fetal brain; Human fetal kidney; Human placenta; Mouse cerebrum; Human retina; Rat placenta; MCF7 cells; U-2 OS cells; 293T cells; C-43 cells; NIH/3T3 cells
    ネガティブコントロール Raji cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Optineurin Antibody (Rabbit mAb) [D24C11] detects endogenous levels of total Optineurin protein.
    タンパク質の局在
    細胞質、細胞質小胞、エンドソーム、ゴルジ装置
    Uniprot ID
    Q96CV9
    Clone
    D24C11
    Synonym(s)
    FIP2, GLC1E, HIP7, HYPL, NRP, OPTN, Optineurin, NEMO-related protein, Optic neuropathy-inducing protein, Transcription factor IIIA-interacting protein, FIP-2, HIP-7, TFIIIA-IntP
    Background
    Optineurin is a ubiquitin‑binding adaptor protein encoded by the OPTN gene that localizes mainly to the cytoplasm and membranous compartments, where it integrates vesicular trafficking, selective autophagy, inflammatory signaling, and immune responses. The protein contains multiple functional modules, including N‑terminal coiled‑coil regions that mediate oligomerization and binding to partners such as myosin VI, Rab8, huntingtin, and Tank‑binding kinase 1, an LC3‑interacting region that connects to the autophagosome membrane, and a C‑terminal ubiquitin‑binding domain that recognizes polyubiquitinated cargo. Through this domain architecture, optineurin acts as a scaffold that couples motor proteins and small GTPases to vesicle membranes, guiding post‑Golgi and endocytic trafficking, and directing membrane‑associated cargo toward degradative or secretory routes. Polyubiquitin binding allows optineurin to function as a selective autophagy receptor that targets damaged organelles, invading pathogens, and protein aggregates to the autophagy–lysosome system, where interaction with LC3 promotes engulfment of tagged cargo into autophagosomes and supports autophagosome–lysosome fusion. Association with TBK1 links optineurin to phosphorylation‑dependent control of autophagy and innate immune signaling, with phosphorylated optineurin showing enhanced affinity for ubiquitin chains and LC3, which strengthens capture and clearance of intracellular pathogens and compromised mitochondria. Crosstalk with NF‑κB signaling occurs through optineurin binding to components of the TNF receptor and related pathways, allowing it to modulate inflammatory transcriptional programs and contribute to balanced cytokine responses during infection and tissue stress. Roles in membrane trafficking extend to the maintenance of organelle integrity and secretory pathway function, where optineurin coordinates vesicle movement, organelle positioning, and turnover of membrane proteins, including at the Golgi apparatus and recycling endosomes. In neuronal and muscle contexts, optineurin‑dependent autophagy contributes to the quality control of long‑lived cells, including removal of dysfunctional mitochondria and degradation of signaling regulators that influence differentiation and survival. Mutations and dysregulation of OPTN associate with normal‑tension glaucoma, amyotrophic lateral sclerosis, Paget’s disease of bone, and other neurodegenerative and inflammatory conditions, where altered ubiquitin recognition, defective vesicle trafficking, or impaired autophagosome–lysosome fusion correlate with axonal degeneration, protein aggregate accumulation, and disturbed immune homeostasis.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください